Posted in | News | Nanobusiness

Roth + Rau and Innovalight Complete Installation of World's First Silicon-Ink Based Solar Cell Pilot Production

Roth + Rau AG and Innovalight have completed the installation of the world's first silicon-ink based solar cell production line. This first pilot manufacturing line has been built and installed at Innovalight, in Sunnyvale, California and has been qualified to operational capability over the last two months of 2008.

“The potential to lower costs by combining Innovalight’s silicon-ink platform and conventional silicon solar cell technology is very impressive”, commented Dr. Dietmar Roth, CEO of Roth & Rau AG, ”Combining the strength of Roth & Rau’s manufacturing expertise and Innovalight’s silicon nanotechnology has enormous potential in the marketplace”, he added.

The pilot line combines the qualities and cost benefits of crystal silicon wafer technology with elegant silicon-ink processing technology to produce low cost, high performance solar cells. Roth & Rau installed the majority of the solar cell manufacturing equipment which has been integrated with Innovalight’s custom proprietary inkjet printing platform and silicon-ink manufacturing systems. This first pilot manufacturing platform installed at Innovalight has the capability of producing 10 Megawatts of solar power and can be easily scaled to many hundreds of megawatts of electricity production.

“Roth & Rau has been a terrific partner to work with,” said Conrad Burke, President & Chief Executive at Innovalight. “They bring a great deal of manufacturing experience to this relationship as we continue to develop our technology toward commercialization,” he added.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.